Re: Farmas USA
Ojo señores, las dos empresas que más han subido hoy son, por una parte ROSG y por otra una tal
Genetic Technologies Limited (NASDAQ:GENE) +54% sólo hoy y +124% los tres últimos días.
Una evolución los dos últimos días, así como su cotización, que se me parecen cantidad a THLD. Terapias génicas contra el cáncer.
Genetic Technologies Limited is engaged in a diagnostic product business. The Company translates genetic tests into products and services. The Company’s cancer diagnostics business focused on building a sustainable stable of products and services. The Company operates in three divisions: genetic testing, including cancer diagnostics; licensing, and research. BREVAGen provides a personalized genetics based risk score for such women, so guiding preventive therapy or advanced monitoring decisions. The majority of its customers are clinicians. The Company’s five overseas subsidiaries include Gtech International Resources Limited, Genetic Technologies (Beijing) Limited, GeneType AG, GeneType Corporation and Phenogen Sciences Inc. In April 2010, Genetic Technologies acquired the assets of Perlegen Sciences Inc., which included non-familial breast cancer risk assessment test BREVAGen.
